"my hypothetical question to you all -

would you take a $3 per sh buyout now or risk another Phase three trial - possibly 3-5 more years of 0 ROI - the lack of management communication - the uncertainty of outcome - significantly more dilution - for an uncertain $20 per share payday or bust?"

Unfortunately is not what we minions want, it's what Shenzhen Hepalink, Eastern and Ori Capital want.

Our fate is in their hands.

IMO ... Koo